Vid Stanulovic

Vid Stanulovic

Auto-generated profile, based on publicly available information

Vid Stanulovic

Global Pharmacovigilance, R&D Sanofi Chilly‐Mazarin France

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2017 in Hepatology
Verified
Journal Article
Closed access
PDF file
CHChristine M. Hunt
Christine M. Hunt
JPJulie I. Papay
Julie I. Papay
VSVid Stanulovic
Vid Stanulovic
ARArie Regev
Arie Regev

2 August 2021 in British Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
VSVid Stanulović
Vid Stanulović
MHMarina Hodolic
Marina Hodolic
DMDimos D. Mitsikostas
Dimos D. Mitsikostas
DPDimitrios Papadopoulos
Dimitrios Papadopoulos

1 August 2011 in International Journal of Cardiology
Verified
Journal Article
Closed access
GPGordana Panic
Gordana Panic
VSVid Stanulovic
Vid Stanulovic
TPTanja Popov
Tanja Popov

21 February 2013 in Drug Safety
Verified
Journal Article
Closed access
PDF file
VSVid Stanulović
Vid Stanulović
MVMauro Venegoni
Mauro Venegoni
BEBrian Edwards
Brian Edwards

1 March 2011 in Int. Journal of Clinical Pharmacology and Therapeutics
Verified
Journal Article
Closed access
VSV. Stanulovic
V. Stanulovic
Romana ZelkoRomana Zelko
Romana Zelko
SKS. Kerpel-Fronius
S. Kerpel-Fronius
We analyzed the predictability of the United States Food and Drug Administration's Medwatch safety alerts on monoclonal antibodies with the aim of assessing the adequacy of their pre-approval safety evaluation.

1 August 2009 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Closed access
VSVid Stanulovic
Vid Stanulovic